These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35131257)

  • 1. The Past and Future of Rare Skin Disease Research and Therapy.
    Onoufriadis A; McGrath JA
    J Invest Dermatol; 2022 Apr; 142(4):1010-1014. PubMed ID: 35131257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dealing with rare diseases in medicine and dermatology -- new developments].
    Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):103-4. PubMed ID: 24494639
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of genetics, pathology and immunology laboratories in the management of rare dermatological diseases].
    Vidaud D; Silve C; Leclerc-Mercier S; Hüe S; Ingen-Housz-Oro S; Bodemer C
    Ann Dermatol Venereol; 2018 Dec; 145(12):795-801. PubMed ID: 30420276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rare diseases -- a transnational dermatological perspective].
    Laimer M
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):367-8. PubMed ID: 24698597
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized medicine for rare neurogenetic disorders: can we make it happen?
    van Eeghen AM; Bruining H; Wolf NI; Bergen AA; Houtkooper RH; van Haelst MM; van Karnebeek CD
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35332073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context for Practice: Clinical Challenges Related to Rare and Uncommon Skin Conditions.
    Gray M
    J Wound Ostomy Continence Nurs; 2017; 44(4):316-317. PubMed ID: 28682852
    [No Abstract]   [Full Text] [Related]  

  • 7. [Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients].
    Laimer M; Prodinger C; Ahlgrimm-Siess V; Hintner H; Bauer JW
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):261-4. PubMed ID: 25721645
    [No Abstract]   [Full Text] [Related]  

  • 8. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
    Titeux M; Izmiryan A; Hovnanian A
    J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular therapies for heritable skin disorders.
    Uitto J; Christiano AM; McLean WH; McGrath JA
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):820-8. PubMed ID: 22158553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The situation of rare skin diseases in Germany].
    Bruckner-Tuderman L; Traupe H; Krieg T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1541-7. PubMed ID: 18026883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing challenges in the diagnosis and treatment of rare genetic diseases.
    Boycott KM; Ardigó D
    Nat Rev Drug Discov; 2018 Mar; 17(3):151-152. PubMed ID: 29242613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mosaic abnormalities of the skin: review and guidelines from the European Reference Network for rare skin diseases.
    Kinsler VA; Boccara O; Fraitag S; Torrelo A; Vabres P; Diociaiuti A
    Br J Dermatol; 2020 Mar; 182(3):552-563. PubMed ID: 30920652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.
    Kristof AS; Petrof BJ; Hamid Q; Kolb M; Landry JS; MacKenzie A; McCormack FX; Murawski IJ; Moss J; Rauch F; Rosas IO; Shapiro AJ; Smith BM; Thomas DY; Trapnell BC; Young LR; Zariwala MA;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1239-1247. PubMed ID: 28763267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare inherited skin diseases and the Genomics England 100 000 Genome Project.
    McGrath JA
    Br J Dermatol; 2016 Feb; 174(2):257-8. PubMed ID: 26871914
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends and Perspectives for Dermatological Research in Europe: An Abstract Title Analysis of ESDR and IID Congresses 2010-2019.
    Bauerdorf F; Kaczmarczyk R; Zink A; Florestan T; Biedermann T
    J Invest Dermatol; 2020 Sep; 140(9S):S197-S200. PubMed ID: 32800177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational genomics for rare cancers: Challenges and opportunity.
    Tan AC; Huang PH
    Semin Cancer Biol; 2020 Apr; 61():iii-iv. PubMed ID: 32092353
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-targeted therapies: Towards equitable development, diagnosis, and access.
    Gaviglio AM; Skinner MW; Lou LJ; Finkel RS; Augustine EF; Goldenberg AJ
    Am J Med Genet C Semin Med Genet; 2023 Mar; 193(1):56-63. PubMed ID: 36688577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 65 YEARS OF THE DOUBLE HELIX: Could Watson and Crick have envisioned the true impact of their discovery?
    Sussman I
    Endocr Relat Cancer; 2018 Aug; 25(8):E9-E11. PubMed ID: 29980643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Society for Dermatological Research (ESDR): Shifting Scope and Expanding Boundaries, Promoting Cutaneous Biology Research across Europe and beyond.
    Schmuth M; Gilliet M; Griffiths CEM; Barker JN
    J Invest Dermatol; 2017 Sep; 137(9):1817-1819. PubMed ID: 28843291
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment.
    Relton CL; Davey Smith G
    PLoS Med; 2010 Oct; 7(10):e1000356. PubMed ID: 21048988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.